Loading...
•
Sep 30, 2025
Prestige Consumer Q2 2026 Earnings Report
Prestige Consumer Healthcare Inc. reported its second quarter and first half fiscal 2026 results.
Key Takeaways
Prestige Consumer Healthcare Inc. surpassed sales and earnings expectations in Q2 fiscal 2026, driven by Clear Eyes® supply timing and retailer orders. The company maintained its financial profile and repurchased shares, while reaffirming its fiscal 2026 revenue outlook and updating its Adjusted Diluted EPS outlook to the high end of the previous range.
Revenue for Q2 fiscal 2026 was $274.1 million, exceeding outlook.
Diluted EPS was $0.86, and Adjusted Diluted EPS was $1.07.
Approximately 1.1 million shares were repurchased opportunistically in Q2.
Fiscal 2026 revenue outlook remains unchanged, while Adjusted Diluted EPS outlook was updated to $4.54 to $4.58, the high end of the previous range.
Revenue by Segment
Forward Guidance
For fiscal year 2026, Prestige Consumer Healthcare Inc. reaffirms its net sales outlook and updates its Adjusted Diluted EPS outlook to the higher end of the previous range, driven by strong financial profile and share repurchases.
Positive Outlook
- Commitment to rebuilding long-term supply chain capacity in Clear Eyes.
- Expectation to close the Pillar5 transaction as planned.
- Reaffirming fiscal 2026 net sales outlook.
- Anticipated eye care supply improvements in the second half of the fiscal year.
- Expecting earnings per share at the higher end of the previous range ($4.54 to $4.58).
Challenges Ahead
- Approximate 1.5% to 3.0% decrease in organic revenue growth.
- No specific negative factors were highlighted in the forward guidance summary, but the revenue decrease is noted.
- Potential challenges in meeting demand for Clear Eyes due to limited supply capacity.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...